
|Articles|December 1, 2018
- Pharmaceutical Executive-12-01-2018
- Volume 38
- Issue 12
Pharmaceutical Executive, December 2018 Issue (PDF)
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Science & Finance: The Biotech Blendover 7 years ago
Europe’s Digital Health Path Still at a Crossroadsover 7 years ago
Lessons for Pharma from the Merck Cyber Attackover 7 years ago
Securing a Winning Strategy for Real-World Evidenceover 7 years ago
RWE: Answering Questions in Rare Diseaseover 7 years ago
Measuring the Probability of Pricing and Access Successover 7 years ago
Four Challenges for AI in the Life Sciencesover 7 years ago
Country Report: MalaysiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The New Healthy Aging Imperative and What It Means for Pharma
2
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
3
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
4
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
5




